Left Menu
Development News Edition

Vaccine hopes, global M&A boost European stocks

European stocks kicked off the week on a positive note, as hopes of a coronavirus vaccine and a flurry of global M&A activity overshadowed worries about a disorderly Brexit. The pan-European STOXX 600 index rose 0.7% by 0711 GMT on Monday, hitting its highest level in over a week, while the German and French indexes clocked similar gains.

Reuters | Updated: 14-09-2020 12:56 IST | Created: 14-09-2020 12:56 IST
Vaccine hopes, global M&A boost European stocks

European stocks kicked off the week on a positive note, as hopes of a coronavirus vaccine and a flurry of global M&A activity overshadowed worries about a disorderly Brexit.

The pan-European STOXX 600 index rose 0.7% by 0711 GMT on Monday, hitting its highest level in over a week, while the German and French indexes clocked similar gains. News over the weekend that AstraZeneca had resumed clinical trials of its COVID-19 vaccine after being suspended last week sparked a wave of buying across global stocks. The British drugmaker's shares rose 0.5%.

Meanwhile, U.S. chipmaker Nvidia Corp said it would buy UK-based chip designer Arm from Japan's SoftBank Group for as much as $40 billion in a deal set to reshape the global semiconductor landscape, spurring a 1% gain in Europe's tech sector. Frankfurt-listed shares of Immunomedics shot up 109.7% on news Gilead Sciences will acquire the U.S. biopharmaceutical company for $21 billion.

However, adding to fears of a messy departure for Britain from the European Union, car industries from both sides warned that failure to secure a free trade agreement would cost the sector 110 billion euros ($130 billion) in lost trade over the next five years.


TRENDING

OPINION / BLOG / INTERVIEW

Uganda COVID-19 response: Was off to a good start but reopening dwindled prospects

Uganda has shown success in using health information to enhance efficiency of disease surveillance, reporting and monitoring. The success, however, has critical challenges confronting it as the country resumes normal activities....

New farm bills in India: Focusing on farms or farmers?

... ...

Kenya’s COVID-19 response: Chaos amid lack of information

Confusing numbers and scanty information on how effective curfews and lockdowns have been in breaking transmission have amplified coordination and planning challenges in Kenyas response to COVID-19. Without accurate data, it is impossible t...

Farkhad Akhmedov: Calculating the price of impunity from the law

In insistences such as the battle over the Luna, Akhmedov has resorted to extreme legal machinations to subvert the High Courts decision and keep his assets from being seized. ...

Videos

Latest News

Parliamentary panel on data protection seeks written explanation from top officials of Twitter on showing Ladakh as part of China.

Parliamentary panel on data protection seeks written explanation from top officials of Twitter on showing Ladakh as part of China....

FTSE 100 hits 6-month low on lockdown fears, vaccine uncertainty

Londons FTSE 100 fell to its lowest level in six months on Wednesday as investors took cash off the table on worries of more virus curbs and uncertainty over a coronavirus vaccine, with homebuilders and energy stocks leading the declines. T...

Poland ‘slammed the door shut’ on legal and safe abortions: Human rights experts

In a statement on Tuesday, the rights experts also called on the Polish authorities to safeguard the rights of men and women protesting against the ruling. Across the country, thousands took to the streets in protest of the ruling by the ...

European stocks hit mid-June low on report France mulling national lockdown

European stocks hit their lowest level since mid-June on Wednesday following a report France was mulling a month-long national lockdown to combat a surge in coronavirus infections.The pan-European STOXX 600 index fell 1.6 by 0808 GMT, while...

Give Feedback